EN-450T5/W N/A

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2018-06-22 for EN-450T5/W N/A manufactured by Fujifilm Corporation.

Event Text Entries

[112026664] The opinion of the doctor who reported the information on the three cases is that: the ischemia could have been triggered by prolonged pressure of a balloon applied to the hepatic portal region (where the hepatic artery and portal systems are running). In addition, a trans-oral entry of the scope and prone position, and, in particular, increased pressure of the body under general anesthesia could increase the risk of developing ischemia. According to the information reported to date by the reporting doctor, the events could be related to the facts that patients were children, the procedures were performed under general anesthesia, the patients were in prone position, and the scopes were inserted through the mouth. Please refer to the attached report. These events are still under investigation at (b)(4). The investigation will assess these factors as potential causes. A supplemental report will be submitted when additional information is available and the investigation is concluded. [(b)(4)].
Patient Sequence No: 1, Text Type: N, H10


[112026665] This report is in regards to one (case 1) of three separate cases reported on (b)(6) 2018, to have occurred in (b)(6); where pediatric patients developed hepatic ischemia after a trans-oral dbe or dberc procedure. In all the cases, the liver enzyme values (ast and alt) increased to more than 1000 after the procedure, the procedures were performed under general anesthesia and in a prone position. This particular case reported in this mdr, case 1) references site a and regards a pediatric patient with peutz-jeghers syndrome. The following are additional details of this case: the purpose of the procedure was to perform a polypectomy, which was completed. After the procedure, hepatic enzyme levels of the patient increased: ast level went up to 6336 iu/l and alt4398 iu/l. The patient did not complain about any discomfort in particular after the procedure although she vomited several times. The following day she developed a fever (37c), vomited several times, and complained about stomach pains intermittently. In response to that, iv, resting, and fasting were ordered, which led to prolongation of the hospital stay. The patient recovered and was discharged on (b)(6) 2013. The events are still under investigation at (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3001722928-2018-00053
MDR Report Key7629420
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2018-06-22
Date of Report2018-12-10
Date of Event2013-02-08
Date Mfgr Received2018-11-12
Date Added to Maude2018-06-22
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional0
Initial Report to FDA0
Report to FDA3
Event Location3
Manufacturer ContactSAFETY OFFICER
Manufacturer Street798 MIYANODAI KAISEI-MACHI
Manufacturer CityASHIGARAKAMI-GUN, KANAGAWA 258-8538
Manufacturer CountryJA
Manufacturer Postal258-8538
Manufacturer G1FUJIFILM CORPORATION
Manufacturer Street798 MIYANODAI KAISEI-MACHI
Manufacturer CityASHIGARAKAMI-GUN, KANAGAWA 258-8538
Manufacturer CountryJA
Manufacturer Postal Code258-8538
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameEN-450T5/W
Generic NameENDOSCOPE
Product CodeFDA
Date Received2018-06-22
Model NumberEN-450T5/W
Catalog NumberN/A
Lot NumberN/A
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerFUJIFILM CORPORATION
Manufacturer Address798 MIYANODAI KAISEI-MACHI ASHIGARAKAMI-GUN, KANAGAWA 258-8538 JA 258-8538


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2018-06-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.